veto-engineered allogeneic human hepatocyte therapy (Isogenis)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameveto-engineered allogeneic human hepatocyte therapy (Isogenis)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsRejection of liver transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIsogenis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIsogenis Inc
Active IndicationsN/A
Inactive IndicationsRejection of liver transplantation

Other Information

ATC CodeN/A
Related LinksN/A